Target- |
Mechanism- |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date25 Jun 2019 |
100 Clinical Results associated with Foshan Nanhai Zhongnan Pharmaceutical Factory
0 Patents (Medical) associated with Foshan Nanhai Zhongnan Pharmaceutical Factory
100 Deals associated with Foshan Nanhai Zhongnan Pharmaceutical Factory
100 Translational Medicine associated with Foshan Nanhai Zhongnan Pharmaceutical Factory